Your browser doesn't support javascript.
Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients.
Antar, Annukka A R; Yu, Tong; Pisanic, Nora; Azamfirei, Razvan; Tornheim, Jeffrey A; Brown, Diane M; Kruczynski, Kate; Hardick, Justin P; Sewell, Thelio; Jang, Minyoung; Church, Taylor; Walch, Samantha N; Reuland, Carolyn; Bachu, Vismaya S; Littlefield, Kirsten; Park, Han-Sol; Ursin, Rebecca L; Ganesan, Abhinaya; Kusemiju, Oyinkansola; Barnaba, Brittany; Charles, Curtisha; Prizzi, Michelle; Johnstone, Jaylynn R; Payton, Christine; Dai, Weiwei; Fuchs, Joelle; Massaccesi, Guido; Armstrong, Derek T; Townsend, Jennifer L; Keller, Sara C; Demko, Zoe O; Hu, Chen; Wang, Mei-Cheng; Sauer, Lauren M; Mostafa, Heba H; Keruly, Jeanne C; Mehta, Shruti H; Klein, Sabra L; Cox, Andrea L; Pekosz, Andrew; Heaney, Christopher D; Thomas, David L; Blair, Paul W; Manabe, Yukari C.
  • Antar AAR; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Yu T; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Pisanic N; Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Azamfirei R; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Tornheim JA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Brown DM; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Kruczynski K; Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Hardick JP; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sewell T; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Jang M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Church T; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Walch SN; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Reuland C; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Bachu VS; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Littlefield K; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Park HS; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Ursin RL; Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Ganesan A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Kusemiju O; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Barnaba B; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Charles C; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Prizzi M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Johnstone JR; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Payton C; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Dai W; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Fuchs J; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Massaccesi G; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Armstrong DT; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Townsend JL; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Keller SC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Demko ZO; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Hu C; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Wang MC; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Sauer LM; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Mostafa HH; Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Keruly JC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Klein SL; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Cox AL; Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Pekosz A; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Heaney CD; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Thomas DL; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Blair PW; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Manabe YC; Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Open Forum Infect Dis ; 8(6): ofab195, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1258789
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

Sustained molecular detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in the upper respiratory tract (URT) in mild to moderate coronavirus disease 2019 (COVID-19) is common. We sought to identify host and immune determinants of prolonged SARS-CoV-2 RNA detection.

METHODS:

Ninety-five symptomatic outpatients self-collected midturbinate nasal, oropharyngeal (OP), and gingival crevicular fluid (oral fluid) samples at home and in a research clinic a median of 6 times over 1-3 months. Samples were tested for viral RNA, virus culture, and SARS-CoV-2 and other human coronavirus antibodies, and associations were estimated using Cox proportional hazards models.

RESULTS:

Viral RNA clearance, as measured by SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR), in 507 URT samples occurred a median (interquartile range) 33.5 (17-63.5) days post-symptom onset. Sixteen nasal-OP samples collected 2-11 days post-symptom onset were virus culture positive out of 183 RT-PCR-positive samples tested. All participants but 1 with positive virus culture were negative for concomitant oral fluid anti-SARS-CoV-2 antibodies. The mean time to first antibody detection in oral fluid was 8-13 days post-symptom onset. A longer time to first detection of oral fluid anti-SARS-CoV-2 S antibodies (adjusted hazard ratio [aHR], 0.96; 95% CI, 0.92-0.99; P = .020) and body mass index (BMI) ≥25 kg/m2 (aHR, 0.37; 95% CI, 0.18-0.78; P = .009) were independently associated with a longer time to SARS-CoV-2 viral RNA clearance. Fever as 1 of first 3 COVID-19 symptoms correlated with shorter time to viral RNA clearance (aHR, 2.06; 95% CI, 1.02-4.18; P = .044).

CONCLUSIONS:

We demonstrate that delayed rise of oral fluid SARS-CoV-2-specific antibodies, elevated BMI, and absence of early fever are independently associated with delayed URT viral RNA clearance.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Language: English Journal: Open Forum Infect Dis Year: 2021 Document Type: Article Affiliation country: Ofid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Language: English Journal: Open Forum Infect Dis Year: 2021 Document Type: Article Affiliation country: Ofid